Bio-America Stock Forecast for 2023 - 2025 - 2030

Updated on 05/02/2024

Stock Rating
0
Price Target
0.00
Consensus
-
Downside
-100.00%
Analysts
0
Stock Rating
0
Downside
-100.00%
Analysts
0
Price Target
0.00

Bio-America Stock Forecast and Price Target

Bio-America's stock price reaches the average target of 0.00 by 2025 as expected recently by notable experts, there would be a potential downside of approximately 0 from the last closing price in August, 2021. This possible increase is based on a high estimate of 0.00 and a low estimate of 0.00. If you're not interested in BOAA stock, you may be interested in its competitors.

0.00

N/A

-

Bio-America Fair Value Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
HLS Stock Forecast HLS Therapeutics Outperform 15
C$4.65 Buy/Sell C$6.07 -23.01%
MDP Stock Forecast Medexus Pharmaceuticals Outperform 0
C$1.75 Buy/Sell C$4.08 71.43%
VPH Stock Forecast Valeo Pharma Outperform 0
C$0.11 Buy/Sell C$0.83 354.55%
PHRX Stock Forecast Pharmadrug - 0
C$0.05 Buy/Sell C$0.00 -100.00%
FFLW.F Stock Forecast Fire & Flower Holdings - 6
$0.29 Buy/Sell $9.30 -100.00%

Bio-America Revenue Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
TCAN Stock Forecast TransCanna Holdings - 0
C$0.01 Buy/Sell C$7.80 -100.00%
PBS Stock Forecast Pacgen Life Science - 0
0.00 Buy/Sell 0.00 0.00%
FVPI Stock Forecast FV Pharma International - 0
0.00 Buy/Sell 0.00 0.00%

Bio-America Dividend per Share Forecast for 2023 - 2025 - 2030

Bio-America Free Cash Flow Forecast for 2023 - 2025 - 2030

Bio-America EBITDA Forecast for 2023 - 2025 - 2030

Bio-America EBIT Forecast for 2023 - 2025 - 2030

Bio-America EPS Price Prediction Forecast for 2023 - 2025 - 2030